Autotaxin Emerges as a Therapeutic Target for Idiopathic Pulmonary Fibrosis: Limiting Fibrosis by Limiting Lysophosphatidic Acid Synthesis

Схожие документы

• The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer
  по: Erstad, Derek J., et al.
  Опубликовано: (2017)
• Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis
  по: Black, Katharine E., et al.
  Опубликовано: (2016)
• The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin–lysophosphatidic acid as a new therapeutic target?
  по: Gallardo, Felipe S., et al.
  Опубликовано: (2021)
• Idiopathic Pulmonary Fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets
  по: Hewlett, Justin C., et al.
  Опубликовано: (2018)
• New Therapeutic Targets in Idiopathic Pulmonary Fibrosis. Aiming to Rein in Runaway Wound-Healing Responses
  по: Ahluwalia, Neil, et al.
  Опубликовано: (2014)